Follow this preprint

SGLT2 inhibition mitigates perturbations in nephron segment-specific metabolic transcripts and mTOR pathway activity in kidneys of young persons with type 2 diabetes

Jennifer A. Schaub, Fadhl M. AlAkwaa, Phillip J. McCown, Abhijit S. Naik, Viji Nair, Sean Eddy, Rajasree Menon, Edgar A. Otto, John Hartman, Damian Fermin, Christopher O’Connor, Markus Bitzer, Roger Harned, Patricia Ladd, Laura Pyle, Jeffrey B. Hodgin, Frank C. Brosius III, Robert G. Nelson, Matthias Kretzler, Petter Bjornstad
doi: https://doi.org/10.1101/2022.07.23.22277943
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2022.07.23.22277943
History 
  • July 24, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Jennifer A. Schaub1,*,
  2. Fadhl M. AlAkwaa1,*,
  3. Phillip J. McCown1,*,
  4. Abhijit S. Naik1,*,
  5. Viji Nair1,
  6. Sean Eddy1,
  7. Rajasree Menon1,
  8. Edgar A. Otto1,
  9. John Hartman1,
  10. Damian Fermin1,
  11. Christopher O’Connor1,
  12. Markus Bitzer1,
  13. Roger Harned2,
  14. Patricia Ladd2,
  15. Laura Pyle3,
  16. Jeffrey B. Hodgin1,
  17. Frank C. Brosius III1,4,
  18. Robert G. Nelson5,
  19. Matthias Kretzler1,†,# and
  20. Petter Bjornstad3,6,†,#
  1. 1Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI
  2. 2Department of Radiology, University of Colorado School of Medicine, Aurora, CO, USA
  3. 3Department of Pediatrics, Section of Endocrinology and Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, CO, USA
  4. 4Division of Nephrology, The University of Arizona College of Medicine Tucson, Tucson, AZ
  5. 5Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA
  6. 6Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, CO, USA
  1. ↵†Corresponding Authors: Matthias Kretzler, M.D. Medicine/Nephrology and Computational Medicine and Bioinformatics University of Michigan 1560 MSRB II 1150 W. Medical Center Dr.-SPC5676 Ann Arbor, MI 48109-5676 Office: 734-615-5757 Fax: 734-763-0982 Email: kretzler{at}umich.edu Petter Bjornstad, M.D. Section of Endocrinology, Department of Pediatrics Division of Renal Diseases and Hypertension, Department of Medicine University of Colorado School of Medicine 13123 E 16th Ave, Box 465, Aurora, CO 80045-7106 Office: 720-777-4659 Fax: 720-777-7301 Email: petter.m.bjornstad{at}cuanschutz.edu

  1. ↵* Contributed equally to the work presented.

Back to top
Posted July 24, 2022.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
SGLT2 inhibition mitigates perturbations in nephron segment-specific metabolic transcripts and mTOR pathway activity in kidneys of young persons with type 2 diabetes
Jennifer A. Schaub, Fadhl M. AlAkwaa, Phillip J. McCown, Abhijit S. Naik, Viji Nair, Sean Eddy, Rajasree Menon, Edgar A. Otto, John Hartman, Damian Fermin, Christopher O’Connor, Markus Bitzer, Roger Harned, Patricia Ladd, Laura Pyle, Jeffrey B. Hodgin, Frank C. Brosius III, Robert G. Nelson, Matthias Kretzler, Petter Bjornstad
medRxiv 2022.07.23.22277943; doi: https://doi.org/10.1101/2022.07.23.22277943
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.